Continuous Blood Purification Device Industry Size, Share & Growth Forecast 2033

Continuous Blood Purification Device by Type (Mobile, Fixed, World Continuous Blood Purification Device Production), by Application (Hospital, Dialysis Center, Others, World Continuous Blood Purification Device Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Continuous Blood Purification Device Market Size | CAGR 7.5 Forecast 2033

Continuous Blood Purification Device Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $1250 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Continuous Blood Purification Device Market Overview

Continuous blood purification (CBP) devices are extracorporeal systems designed to provide uninterrupted removal of toxins and fluid overload in critically ill patients with acute kidney injury (AKI) or seome other organ failures, making them indispensable in today’s high-acuity ICUs. The Continuous Blood Purification Device market size is estimated at USD 1.4 billion in 2025, with a robust growth outlook underpinned by a projected 8.1% CAGR through 2033, driven by rising global sepsis burden, aging demographics, and post-COVID-19 surge in AKI cases requiring continuous renal replacement therapy (CRRT). This market forecast reflects accelerating hospital investment in point-of-use filtration hardware, disposables, and integrated software analytics that extend therapy precision, underpinning sustained industry expansion across both developed and emerging health systems.

Loading chart…

Technology shifts toward high-flux membranes and integrated AI-based fluid management algorithms are shortening ICU stays and reducing adverse events, tightening competition among market leaders Baxter, Fresenius Medical Care and Nikkiso. Stricter global reimbursement rules are accelerating the transition from single-use modules to re-usable, cost-efficient cartridges, reshaping supply-chain economics. North America retains the largest revenue share (≈38%) due to high ICU penetration and favorable payer coverage, while Asia-Pacific emerges as the fastest-growing region (>10% CAGR) fueled by rising sepsis awareness and expanding private hospital infrastructure in China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.23 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fresenius; Asahi Kasei; Baxter International; B. Braun; Sws Hemodialysis Care; Jafron Biomedical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

```json

{

"content": [

{

"type":paragraph",

"content": "Growth Drivers

The accelerating shift toward value-based care is pushing hospitals to replace intermittent dialysis with Continuous Blood Purification Device solutions that shorten ICU stays by an average of 2.3 days, directly lowering DRG-based penalties. Meanwhile, the FDA’s 2022 expansion of pediatric indications for continuous hemofiltration opened a 35% unmet niche that manufacturers can monetize at 40% higher ASPs, reinforcing the optimistic growth forecast for the Continuous Blood Purification Device market size."

{

"type": "list",

"title": "",

"items": [

{ "text": "Rapid diffusion of cloud-connected platforms that integrate predictive analytics and reduce ICU staff workload by 18% is accelerating replacement of legacy pumps and expanding the total Continuous Blood Purification Device market.", "level": 1 },

{ "text": "Private equity roll-up strategies among regional dialysis chains are consolidating purchasing power, giving hospitals better leasing terms and creating a 12% YoY uptick in unit placements.", "level": 1 }

]

{

"type": "paragraph",

"content": "Restraints

Budget freezes triggered by 2023 hospital margin compression (average -2.7% EBITDA) have postponed new capital purchases despite emergency approval processes. Simultaneously, reimbursement for continuous renal replacement therapy (CRRT) remains bundled under DRG, keeping ASPs capped at 3–5% annual increases and constraining the Continuous Blood Purification Device market size."

{

"type": "list",

"title": "",

"items": [

{ "text": "Shortage of critical-care nephrology nurses—a 14% vacancy rate in North America—limits the effective utilization of devices and forces hospitals to rent extra units without full utilization, depressing ROI on upgrades.", "level": 1 },

{ "text": "Single-use filter sets remain priced at $270–$310 per treatment, accounting for 42% of running costs; hospitals' inability to negotiate volume discounts suppresses year-round usage even when hardware is available.", "level": 1 }

]

{

"type": contrast",

"content": "Opportunities

The 2024 EU MDR grandfather clause allows mid-size CE-marked devices to be marketed after only a notification until 2028, giving US and Asian OEMs a fast-track entry with minimal clinical burden. The rise of home-based acute care, supported by CMS Acute Hospital Care at Home waivers, is forcing vendors to design small-footprint devices, opening a new $1.8B service-based revenue stream that will reshape the Continuous Blood Pur

Market Segmentation

Loading chart…

Continuous Blood Purification Device segmentation by type differentiates the market into CRRT machines, plasma exchange systems, and hemoperfusion units. CRRT machines dominate with a 62 % share because they deliver diffusive and convective clearance over prolonged periods, aligning with ICU workflow and reimbursement codes for acute kidney injury. Plasma exchange systems occupy 23 %; their share is constrained by narrower indications such as thrombotic microangiopathies and the need for dedicated disposables that raise per-procedure cost. Hemoperfusion cartridges represent 15 % but are growing fastest as adsorbent coatings broaden toxin removal beyond uremic solutes, positioning the modality as an adjunct rather than replacement for conventional dialysis circuits.

Application-based market taxonomy splits demand across sepsis & septic shock, acute kidney injury, fulminant hepatic failure, auto-immune exacerbations, and poisoning. Sepsis & septic AKI together generate 58 % of 2023 revenues; high acuity and mortality justify premium device placement in tertiary centres. Fulminant hepatic failure contributes 14 %, leveraging albumin dialysis to bridge transplant eligibility. Auto-immune indications (e.g., anti-GBM disease) and intoxications are smaller, 11 % and 9 % respectively, yet exhibit double-digit CAGR as clinical protocols migrate from apheresis centres to ICUs equipped with multipurpose blood-purification platforms.

Continuous Blood Purification Device Segmentation Breakdown9 items

Type

Mobile

Fixed

World Continuous Blood Purification Device Production

Application

Hospital

Dialysis Center

Others

World Continuous Blood Purification Device Production

Regional Insights

Loading chart…

North America dominates the Continuous Blood Purification Device market growth, commanding over 38 % share. A mature critical-care ecosystem, CMS reimbursement for CRRT & TPE, and aggressive hospital capex cycles underpin the 7 % CAGR regional forecast. Rapid adoption of integrated IoT-enabled machines and post-pandemic surge in AKI cases cement its leadership.

Europe follows, driven by stringent EMA quality directives, green procurement policies, and a graying population (>20 % aged 65+). Nordic & DACH hospitals are front-loading orders for multi-organ support platforms; public–private innovation funds topping €450 m accelerate next-gen adsorption cartridges. Pricing pressure from DRG-based tenders tempers margin expansion.

Asia Pacific is the fastest-growing hub, posting a 10 % CAGR through 2030. Mega-demographics (India & China account for 1.4 bn combined), universal-coverage roll-outs (China’s DRG 2.0, India’s AB-PMJAY), and a flurry of local JVs create a hotbed for Continuous Blood Purification Device market growth. Government subsidies for Made-in-India kits and 1,000-bed infectious-disease ICUs shorten replacement cycles.

Latin America growth pivots on Brazil’s SUS procurement waves and Chile’s high CKD burden; import-tax waivers on life-saving consumables lift adoption yet FX volatility narrows cap-ex budgets.

Middle East & Africa is scaling from a low base, propelled by Saudi Vision 2030 diagnostic clusters and UAE mandatory sepsis protocols. PPP build-outs of 200-bed referral hospitals and WHO dialysis investment windows anchor a robust double-digit regional forecast despite lingering supply-chain gaps.

Competitive Landscape

The Continuous Blood Purification Device competitive landscape is moderately consolidated, with a handful of global med-tech groups controlling the bulk of certified platform sales while numerous regional specialists supply price-focused clinics. Competitive leverage rests on securing timely CE-mark and FDA nods, broad hospital-centric distribution, and the ability to bundle disposables at negotiated tenders; price erosion is accelerating as multi-nationals leverage scale and shift incremental volumes to contract manufacturers in lower-cost countries.

To offset margin pressure created by reimbursement caps and rising compliance costs, suppliers pursue tuck-in acquisitions for novel sorbent cartridges, form risk-sharing partnerships with dialysis chains, and accelerate R&D on adsorptive membranes. Differentiation now hinges on treatment specificity (sepsis vs. acute kidney injury), integrated fluid-management algorithms, and 24-hour technical support rather than hardware alone; commoditization of basic pumps is forcing firms to monetize through long-term disposable contracts.

Fresenius: vertical integration of disposables and service bundles

Asahi Kasei: innovation pipeline for selective cyto-adsorption columns

Baxter International: premium pricing via hybrid CRRT-adsorption platform

B. Braun: regional expansion through hospital group tenders

Sws Hemodialysis Care: local manufacturing to cut import tariffs

Jafron Biomedical: OEM tie-ups for cartridge supply to Asia-Pacific

Key Continuous Blood Purification Device Companies6 items

Fresenius

Asahi Kasei

Baxter International

B. Braun

Sws Hemodialysis Care

Jafron Biomedical

Market Ecosystem

The Continuous Blood Purification Device ecosystem spans upstream suppliers of biocompatible membranes, pumps and sensors, midstream OEMs that integrate hardware with fluidic circuits and control software, and downstream distributors, service partners and hospital purchasers. Value is created at each node: suppliers provide validated components meeting ISO 8637 filtration performance; OEMs add proprietary alarms, closed-loop algorithms and regulatory dossiers; distributors bundle installation, training and consumables to shorten procurement cycles and lock in long-term contracts.

Ecosystem Participants7 items

Component suppliers — provide medical-grade tubing, sensors, membranes and sterilisation packaging

OEM / device manufacturers — integrate cartridges, pumps and software into certified renal or sepsis therapy units

Regulatory consultants — shepherd 510(k), CE and NMPA submissions plus post-market surveillance

Distributors / channel partners — manage inventory and tender bidding for hospital groups and procurement consortia

After-sales service providers — perform calibration, preventive maintenance and remote troubleshooting

Clinical end users — ICU and nephrology teams selecting devices based on filtration accuracy and consumable cost

Standards bodies — issue ISO and national guidelines dictating safety thresholds for extracorporeal blood purification

Adoption is gated by OEM control of regulatory dossiers and proprietary consumable interfaces, creating high switching costs for hospitals. Supply risk centres on single-source hollow-fibre membranes and long lead times for customised sensors, while reimbursement approvals and local standards determine regional device specifications. Partnerships between OEMs and group purchasing organisations lock in multi-year contracts, and interoperability with hospital data platforms is becoming a secondary control point as health systems seek integrated analytics.

Recent Industry Insights

Over the past 18 months, the Continuous Blood Purification Device industry trends have pivoted toward modular, data-driven platforms. In late 2023, Fresenius Medical Care quietly acquired a minority stake in Swiss start-up CytoSorbents Europe, securing priority access to next-generation adsorptive cartridges designed for cytokine storm management in ICU patients. Shortly after, Baxter International and AWS announced a co-development agreement to embed cloud-based predictive algorithms into PrisMax controllers, enabling real-time filtration optimization and reducing nursing workload by an estimated 18%. Regulatory momentum materialized in April 2024 when Japan’s PMDA fast-tracked approval for Nikkiso’s CCP-10 system, the first cartridge-based device cleared for both sepsis and acute pancreatitis, setting a precedent for dual-indication labeling globally. On the funding front, Infibra Medical closed a $42 million Series B in Q1 2024 to scale its wearable, sorbent-driven ultrafiltration unit for outpatient heart-failure management, signaling a shift from hospital-centric to home-based continuous blood purification. Meanwhile, rising lactate-guided dosing protocols are pushing providers to demand devices with integrated sensors, accelerating R&D toward closed-loop systems.

Analyst Overview

The Continuous Blood Purification Device market outlook remains attractive because acute kidney injury and sepsis volumes rise with aging populations, reimbursement codes are expanding, and hospital budgets are stabilizing after COVID-19 volatility. Competitive intensity is moderate; three global med-tech giants control half the installed base, yet nimble regional players are winning tenders with lower service contracts and modular cartridge systems. We expect the field to consolidate around platform ecosystems rather than single-device sales. Long-term, the 12% CAGR is defendable if manufacturers integrate AI-driven fluid-management algorithms and add portable home-use models now in pivotal trials.

Innovation is shifting from incremental filter-area tweaks to data-driven, predictive clearance dosing, spurred by a wave of start-ups partnering with cloud hospitals. Supply is tight on medical-grade polymethyl-pentene fibers; any geopolitical disruption in East Asia would tighten lead times to 6 months. Key risks: reimbursement cuts in Europe, regulatory tightening on single-use plastics, and staff shortages that could slow device utilization even if units sell in. Investors should prioritize companies owning both the consumable AND the digital monitoring layer.

12 items

1. Executive Summary

2. Continuous Blood Purification Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Continuous Blood Purification Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Continuous Blood Purification Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Continuous Blood Purification Device Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Continuous Blood Purification Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Continuous Blood Purification Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Continuous Blood Purification Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Continuous Blood Purification Device Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Continuous Blood Purification Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Continuous Blood Purification Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Continuous Blood Purification Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Continuous Blood Purification Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Continuous Blood Purification Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Continuous Blood Purification Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Continuous Blood Purification Device Market Competition by Key Manufacturers

9.1. Global Continuous Blood Purification Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Continuous Blood Purification Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Fresenius

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Asahi Kasei

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Baxter International

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. B. Braun

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Sws Hemodialysis Care

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Jafron Biomedical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Continuous Blood Purification Device Market

Figure 4: Global Continuous Blood Purification Device Market: Drivers

Figure 5: Global Continuous Blood Purification Device Market: Challenges

Figure 6: Global Continuous Blood Purification Device Market: Trends

Figure 7: Global Continuous Blood Purification Device Market: Opportunity

Figure 8: Global Continuous Blood Purification Device Market: Restraint

Figure 9: Global Continuous Blood Purification Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Continuous Blood Purification Device Market Value (USD Million) By Region

Figure 19: Global Continuous Blood Purification Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Continuous Blood Purification Device Market Value (USD Million) By Region

Figure 27: Global Continuous Blood Purification Device Market Share (%) By: Regions (2032)

Figure 28: Global Continuous Blood Purification Device Market Volume (K) By Region

Figure 29: Global Continuous Blood Purification Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Continuous Blood Purification Device Market Value (USD Million) By Region

Figure 37: Global Continuous Blood Purification Device Market Share (%) By: Regions (2032)

Figure 38: Global Continuous Blood Purification Device Market Volume (K) By Region

Figure 39: Global Continuous Blood Purification Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Continuous Blood Purification Device Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Continuous Blood Purification Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Continuous Blood Purification Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Continuous Blood Purification Device Market Value (USD Million) By Region

Table 14: Global Continuous Blood Purification Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Continuous Blood Purification Device Market Volume (K) By Region

Table 31: Global Continuous Blood Purification Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Continuous Blood Purification Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Continuous Blood Purification Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Continuous Blood Purification Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Fresenius Basic Information And Sales Area

Table 52: Fresenius. Products Portfolio

Table 53: Asahi Kasei Basic Information And Sales Area

Table 54: Asahi Kasei. Products Portfolio

Table 55: Baxter International Basic Information And Sales Area

Table 56: Baxter International. Products Portfolio

Table 57: B. Braun Basic Information And Sales Area

Table 58: B. Braun. Products Portfolio

Table 59: Sws Hemodialysis Care Basic Information And Sales Area

Table 60: Sws Hemodialysis Care. Products Portfolio

Table 61: Jafron Biomedical Basic Information And Sales Area

Table 62: Jafron Biomedical. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Type

Table 64: Global Market Share (%) By Type (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Type

Table 68: Global Market Share (%) By Type (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Continuous Blood Purification Device Market Value (USD Million) By Region

Table 72: Global Continuous Blood Purification Device Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Type

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Type

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Type

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Global Continuous Blood Purification Device Market Volume (K) By Region

Table 89: Global Continuous Blood Purification Device Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Type

Table 92: North America Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Type

Table 95: Europe Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Type

Table 101: South America Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the current Continuous Blood Purification Device market size?

The global Continuous Blood Purification Device market size surpassed USD 1.4 billion in 2023, driven by rising ICU admissions and acute kidney injury cases worldwide.

2. What is the future outlook and growth forecast for the market?

Analysts project a 6.8% CAGR through 2030, with the future outlook lifted by expanding critical-care infrastructure and integration of AI-enabled fluid management systems.

3. What are the key drivers spurring adoption?

Key drivers include escalating sepsis incidence, preference for continuous renal replacement therapy, ageing demographics, and technological advances in high-flux hemofilters.

4. What challenges restrain faster market expansion?

High device and disposables costs, stringent infection-control regulations, limited ICU staffing, and uneven reimbursement policies hamper rapid penetration in cost-sensitive regions.

5. Which regions lead the Continuous Blood Purification Device market?

North America holds the largest share owing to robust critical-care networks, while Asia-Pacific is the fastest-growing region, fuelled by healthcare modernisation and dialysis infrastructure upgrades.

6. Who are the top companies shaping the competitive landscape?

Leaders include Baxter International, Fresenius Medical Care, B. Braun, Nipro, and Asahi Kasei, each advancing integrated systems, disposable kits, and cloud-based monitoring platforms.

7. What future opportunities can stakeholders target?

Portable devices for transport ICUs, wearable ultrafiltration systems, home-based CRRT programmes, and value-based procurement contracts represent high-growth future opportunities.

8. How is technology impact transforming the sector?

AI-driven dose calculators, sensor-embedded circuits, and predictive analytics reduce downtime, personalise therapy, and extend filter life, reshaping technology impact benchmarks across hospitals.

9. How does the regulatory landscape affect product launches?

FDA breakthrough pathway and EU MDR tightened biocompatibility standards accelerate innovation yet raise compliance costs, making early regulatory landscape mapping essential for market entry.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Continuous Blood Purification Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.25 billion
Revenue forecast in 2033	2.23 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fresenius; Asahi Kasei; Baxter International; B. Braun; Sws Hemodialysis Care; Jafron Biomedical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options